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Abstract
Alzheimer’s Disease (AD) is a devastating neurodegenerative disease that is
characterized by brain atrophy, neuronal and synaptic loss, cognitive decline, trouble handling
activities of daily life, and ultimately leads to death. Worldwide, at least 30 million people
suffer from AD, with 5.8 million suffering in the US alone. Despite extensive basic and clinical
research, the underlying molecular mechanisms behind AD remain largely unknown. There are
four FDA-approved compounds are used for alleviating symptoms but have no curative
potency. The first potentially disease-modifying AD drug, aducanumb, was approved by FDA
in June 2021. The main histopathological traits of AD are the Amyloid-beta (Aβ) peptide and
the tau protein. Aβ aggregates to form extracellular plaques in brain parenchyma and
vasculature while tau forms intraneuronal tangles. Aβ is produced by enzymatic cleavage of the
amyloid precursor protein (APP) in the brain. Once APP cleavage occurs, Ab monomers either
aggregate extracellularly to form buildups of sticky plaque or embed themselves within the
neuronal cell membrane to form pores, causing homeostatic dysregulation and eventually cell
death. The mechanism of membrane pores formed by Ab and the pore structure remain to be
characterized. This study aims to analyze the structure of four Aβ species in lipid membranes.
These are the most abundant form of Aβ, Aβ1-40, and the more cytotoxic form, Aβ1-42, as well as
their pyroglutamylated counterparts, pEAβ3-40 and pEAβ3-42, which are hypertoxic. These
peptides have been studied using biophysical approaches, i.e., circular dichroism, fluorescence
spectroscopy, and Fourier transform infrared spectroscopy. Elucidation of the structure of Aβ
membrane pores provides valuable insight into the mechanism of Aβ toxicity and may help
develop novel therapies for the lethal mystery that is AD.
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Chapter 1

INTRODUCTION
A brief overview of AD pathophysiology
Alzheimer’s Disease (AD) is a neurodegenerative disease characterized by neuronal and
synaptic loss, cognitive impairment, trouble handling daily life activities, and ultimately leads to
death (Lope et al., 2019; NIA, 2017). Worldwide, at least 30 million people suffer from AD, with
5.8 million people suffering in the US alone, making up 60-70% of all global dementia cases
(Services, 2020; Silva et al., 2019). Considering these staggering numbers, it is unsurprising that
there is great scientific interest and public concern around explaining and treating this lifealtering condition. Despite its prevalence, AD pathology is little understood due to many factors,
one being the elusive nature of the early stages, which makes diagnosis difficult before
significant brain damage has already occurred. Over the years, there has been a considerable lack
of success in treating AD in part due to an incomplete understanding of the underlying molecular
mechanisms and failed drug trials.
A key histopathological characteristic of neurodegenerative diseases is a buildup of
abnormally folded proteins. For AD, this includes the accumulation of Amyloid-beta (Aβ)
peptide in the brain in the form of insoluble extracellular plaques and more toxic soluble
oligomers (see below) (Benilova, 2012; Selkoe & Hardy, 2016; Amar et al., 2018). Aβ deposits
are most commonly found in the hippocampus, which is the area of the brain responsible for
memory and cognition (Selkoe et al., 2016; Jack et al., 2016). Synaptic loss is one of the
strongest and most identifiable symptoms of AD and is thought to be in part caused by Aβ3

induced pore formation and tau hyperphosphorylation (see below), as has been observed in many
studies.
One of the most popular theories of AD etiology is the “amyloid cascade hypothesis”, yet
it remains controversial and is still under active debate in the AD research community. The
amyloid cascade hypothesis suggests that Aβ peptide initiates a complex pathogenic cascade (yet
to be fully understood) that causes AD, such as the accumulation of hyperphosphorylated tau
protein, another important player in AD pathology (see below). Aβ monomers build fibrils that
lead to insoluble senile plaques. The plaques can then sequester soluble Aβ oligomers until
reaching a physical capacity, and afterwards excess oligomers are able to diffuse onto
surrounding hydrophobic cell surfaces, especially synaptic membranes, and form pores that lead
to neurotoxic effects. (Selkoe & Hardy, 2016) The main argument against the amyloid cascade
hypothesis is that it does not provide a complete picture due to nuances in a rarer “familial”
subtype of AD, and that plaques are seen in non-AD patients (Selkoe & Hardy, 2016). However,
clinically normal (non-AD) patients have a much lower oligomer to plaque ratio than subjects
with mild or advanced AD. This denotes that oligomers are more toxic than plaques, and are thus
an important area to focus research efforts.
Upon exposure to the brain’s naturally aqueous environment, Aβ peptides become rich in
cross β-sheet structures, which allow them to closely agglomerate or form neurotoxic Ca2+
permeable pores within neuronal membranes. Specifically, Aβ pores take on a β-barrel
conformation as modeled by computer generated images (see Figure 1.2). However, these are
only models and have not yet been experimentally confirmed. This thesis attempts to collect
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experimental evidence for Aβ pore structure. By observing Aβ’s transition between α-helical and
β-sheet structure over exposure to aqueous solution, the structural basis of membrane pore
formation and its subsequent toxic effect will be revealed.

Figure 1.1: Structures (left) and Aβ1-42 (right) monomers determined by solid-state NMR. For Aβ1-40, the N-terminal
8 amino acid residues are not resolved. The backbone is colored blue for beta sheet regions and rose for turn/loop
regions. The structure in membranes is not known. (Tyco, 2011; Wälti et al., 2016)

Spectroscopy
This study aims to observe the structure of the most prevalent and toxic forms of Aβ in
lipid membranes. One of the many ways that protein structure is studied is with spectroscopic
techniques. Spectroscopy is used to study the interaction of matter with the electromagnetic field.
The structure of the matter determines the interaction it has with electromagnetic radiation, so
spectroscopy is used for structural characterization. By measuring the protein’s absorption of
electromagnetic radiation, its structure can be characterized. There are many different types of
spectroscopic techniques used in the study of protein structure, including vibrational
spectroscopy, such as Fourier-transform infrared (FTIR) spectroscopy, which measures the
absorption of light at frequencies corresponding to vibrations of chemical bonds, and electronic
spectroscopy, such as circular dichroism (CD) and fluorescence, which are based on absorption
5

and emission of light due to transitions of electrons between energy levels. Light scattering is yet
another optical spectroscopy method that evaluates the relative particle size based on emission of
light at frequencies of incident radiation. This study uses circular dichroism (CD), fluorescence,
FTIR, and light scattering for analysis of Aβ structure in membranes. Further details of each
spectroscopic technique will be discussed in Chapter 3.

Figure 1.2: ATR-FTIR spectra of Aβ1-42 in membranes at perpendicular polarization of incident light in dry state
(blue) and 4 hours after injection of buffer (red), with assignments of main absorbance bands.
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Chapter 2

BACKGROUND/LITERATURE REVIEW
What is Amyloid Beta?
Monomeric Aβ (~4.5 kDa) is a 37-49 amino acid residue peptide derived from the
enzymatic cleavage of amyloid precursor protein (APP) (~120 kDa) by proteolytic enzymes βand γ- secretase (Benilova, 2012; Selkoe & Hardy, 2016; Chow et al., 2010; Agostinho et al.,
2015; Chen, 2017). Little is known about APP’s biological function, but researchers posit that it
may help with migration of neurons during early development, synaptic formation and repair,
intracellular transport, signaling, and other aspects of neuronal homeostasis (MedlinePlus, 2020;
Kamboh, 2018). Research is still needed to fully understand APP’s biological role.
AD genetic risk factors are linked to the genes PSEN1 and PSEN2 that encode for the
catalytic domain of -secretase (Benilova, 2012; Selkoe & Hardy, 2016), as well as the APP
gene; mutations in these genes lead to early onset AD that constitutes roughly 5% of all AD
cases (Chen, 2017). Another important genetic risk factor is the apolipoprotein E gene, APOE,
which is a susceptibility gene for the most common (~95%), late onset AD. APOE occurs in
three allelic variants: 2, 3, and 4, of which the 4 form increases the AD risk up to 15-fold
(Chen et al., 2021).
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Forms of Aβ
Once APP cleavage is complete, Aβ monomers are free to interact with one another and
agglomerate into extracellular plaques or into metastable (spreadable) oligomers (Benilova,
2012; Selkoe & Hardy, 2016). The most common forms of Aβ are the 40- and 42- residue
species (Aβ1-40 and Aβ1-42), but many shorter forms exist as well due to cleavage by aminoand/or carboxy-peptidases, each with their unique solubility and stability (Benilova, 2012; Beel
& Sanders, 2008; O’Brien & Wong, 2011). Depending on the solubility of Aβ monomer in the
brain’s naturally aqueous environment, it will either agglomerate into protofibrils which later
turn into extracellular plaques or metastable (spreadable) oligomers (Benilova, 2012; Selkoe &
Hardy, 2016). Insoluble monomers agglomerate into protofibrils and form plaques. Plaque cores
from post-mortem AD brains were shown to be comprised of insoluble forms of Aβ. Soluble
monomers of Aβ tend to oligomerize to form dimers, trimers, and various other oligomers and
are thought to be more toxic than the plaques and may embed themselves into neuronal
membranes to form pores (Amar et al., 2018).
Additionally, more cytotoxic versions of Aβ have been found in AD brains. These Nterminally truncated and pyroglutamylated (at Glu3 or Glu11) forms of Aβ (pEAβ) make up
between 10-50% of total Aβ in brains of AD subjects (Mandler et al., 2014). pEAβ is more toxic
due to its higher tendency to form β-sheets and is more efficient in forming detrimental pores
that disrupt ion flow and consequently damage neuronal function (Dammers et al., 2015; Arispe
et al., 1993; Shirwany et al., 2007; Prangkio et al., 2012).

8

Figure 2.1: 42-residue Aβ (top) vs. pEAβ (bottom). Notice the pEAβ is shorter due to being N-terminally truncated.
Reference: (Wolf, 2012)

Aβ oligomers and cytotoxicity
The majority of experimentation on Aβ oligomers is done in vitro, using oversimplified
conditions such as an aqueous buffer with or without added organic solvents. This makes it
easier to see the characteristics of the peptide but could potentially not explain its biological
behavior. Most of the data available on Aβ’s structure is from synthetic Aβ, and it is unclear
whether these accurately resemble natural Aβ found in AD brain (Selkoe & Hardy, 2016) In vivo
experimentation in human subjects involves biomarkers and brain imaging, and can often be
used in presymptomatic patients to begin early treatment. A goal for future AD research is to
quantify all Aβ peptides in plasma of presymptomatic and symptomatic AD patients (Selkoe &
Hardy, 2016). There is a lack of common agreed upon experimental description of toxic Aβ
oligomer that makes interpreting and comparing data from different research groups difficult.
Furthermore, no single mechanism explains all aspects of Aβ oligomer toxicity. Nonetheless, it
is clear that Aβ oligomers produce a cytotoxic effect, even if the exact mechanism remains
unknown.
9

Not all oligomeric Aβ species affect the same neuronal signaling pathway. For example,
Aβ56, a 56-kDa oligomer, was able to selectively activate CaMKIIα receptors in Tg2576
transgenic mice while other purified Aβ oligomer species could not (Amar et al., 2018). Contrary
to early belief, it was found that the oligomeric form of Aβ is far more toxic than the fibrillar
plaques, as they were shown to impair synaptic function, structure, and number in healthy adult
rats (Selkoe & Hardy, 2016). Plaque cores, in contrast, did not affect long-term potentiation
(LTP) and dendritic spine structure in the rats, but oligomers did, further providing evidence for
oligomer’s higher toxicity (Selkoe & Hardy, 2016). Additionally, soluble oligomers of Aβ1-42
isolated from post-mortem AD brains were found to decrease synapse number, inhibit LTP, and
enhance long-term synaptic depression in rodent hippocampus (Selkoe & Hardy, 2016). Synaptic
loss is one of the strongest quantitative correlates of dementia in AD, so these findings point to
oligomers having a large role in AD pathophysiology.

Tau protein
The relationship between Aβ and tau is still unresolved, but many lines of evidence
suggest they are linked. Aβ is believed to initiate tau hyperphosphorylation (the addition of
phosphate groups to a molecule), causing neuritic dystrophy (Benilova, 2012; Amar et al., 2018;
Barthelemy et al., 2020; Sato et al., 2018). Microtubule-associated protein tau functions normally
to stabilize neuronal microtubules. Tau is normally phosphorylated a post-translational
modification, which regulates its normal function in axonal stabilization (Barthelemy et al,
2020). However, hyperphosphorylated tau protein agglomerates and forms intracellular
neurofibrillary tangles (NFTs), which could trap vital functional proteins and damage neurons’
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axonal transport (Benilova, 2012; Amar et al., 2018; Barthelemy et al., 2020; Sato et al., 2018).
There are still many gaps in our understanding of this mechanism.
Distinct oligomeric species of Aβ exert different effects on neuronal signaling and tau
biology. For example, tau is hyperphosphorylated with low-n oligomers at different sites than
high-n oligomers, such as Aβ56 (Amar, 2018). A study conducted in 2014 found that
pyroglutamylated forms of Aβ might initiate tau-dependent cytotoxicity as was seen in postmortem brains (Mandler et al. 2014).

Aβ-induced pore formation
Aβ oligomers tend to insert into neuronal cell membranes and form pores that act as ion
channels, which disrupts cellular ionic homeostasis (Dammers et al., 2015; Peters et al., 2016).
Disruption of ionic homeostasis is especially devastating for neurons because they rely on a
sodium/potassium gradient in order to form action potential. If this gradient is disrupted, then
cellular function will greatly reduce or cease altogether. Oligomers were specifically found to
physically interact with the membrane lipids cholesterol and ganglioside, both of which are
important in maintaining membrane structure around ion channels (Coralie; 2016). Aβ oligomers
were shown to form calcium-permeable pores in rat hippocampal neurons, which disrupt
synaptic transmission and are thought to be primary contributors to both AD and Parkinson’s
disease (Peters et al., 2016). CD and fluorescence spectroscopy revealed that Aβ25-35 (a cytotoxic
Aβ fragment) formed the most efficient pores in lipid membranes when in β-sheet conformation
(Kandel et al., 2017).
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Current therapies
Until recently, there have been no disease-modifying drugs available for AD despite
rigorous research, in part due to an incomplete understanding of AD’s molecular mechanism,
which leads to a lack of drug targets on which to base therapies. Four FDA-approved drugs
(donepezil, rivastigmine, galantamine, and memantine) are only remedies for symptoms and
have no curative potency. A monoclonal antibody against A aggregates, aducanumab, was
recently approved by FDA based on its ability to clear A from brain and retard cognitive
decline (see below). In addition to immunotherapy approaches, pharmacological efforts have
been directed to suppress Aβ accumulation in the brain by inhibition of β- and γ- secretase, but
these endeavors have not been successful thus far mostly because of severe adverse events such
as cerebral edema, microhemorrhage, or cancer (Benilova, 2012; Selkoe & Hardy, 2016;
Elmaleh, 2019; Alzheimer’s Association, 2019). “Membrane therapies” are being explored to see
if alteration of lipid membrane structure can inhibit amyloid pore formation (Coralie, 2016).
As of June 7, 2021, Aducanumab, sponsored by the biotech company Biogen, was
approved by the FDA and has been shown to reduce amyloid plaques in clinical studies
(Cummings et al., 2021). Aducanumab is a monoclonal antibody that targets aggregated Aβ.
Studies have shown that the drug has a high affinity for the neurotoxic oligomeric species of Aβ.
Specifically, it binds a linear epitope formed by amino acids 3-7 of the Aβ peptide (Arndt et al.,
2018). Amyloid plaques were markedly decreased by the drug, as observed by positron emission
tomography (PET). Phosphorylated tau in the cerebrospinal fluid and medial temporal NFTs
were also reduced in some patients, which points back to the amyloid hypothesis (Cummings et
al., 2021). The Neuropsychiatric Inventory showed 87% reduction in EMERGE scores (a phase 3
12

study examining cognition, function, and behavior of AD patients) (Haeberlein, 2020). However,
the drug is under active debate in the community. Skeptics note that previous clinical trials of
Aβ-targeting drugs have been negative, and much criticism is being directed to the FDA for
working too closely with Biogen.

Research question
This project will study the structure of the most abundant and toxic forms of Aβ, i.e.,
Aβ1-42, Aβ1-40, and the hypertoxic pyroglutamylated species pEAβ3-42 and pEAβ3-40 via multiple
spectroscopic techniques. These include CD, fluorescence, light scattering, FTIR, and Attenuated
total reflection-FTIR (ATR-FTIR) spectroscopic techniques.
Little is known about Aβ’s pore-forming capabilities. More can be known about the toxic
alteration of lipid membranes in AD by analyzing Aβ’s structure in lipid membranes. Since ionconducting pores formed in neuronal membranes by Aβ contribute to neurotoxicity, this data will
reveal the structural basis of membrane pore formation and its subsequent toxic effect.
Comparison of the structure of Aβ peptides in aqueous buffer and when reconstituted in
lipid membraned will identify the structural transition of the peptide upon insertion into cellular
membranes, such as the plasma, endoplasmic reticulum, or mitochondrial membranes of
neurons. It is anticipated that membrane insertion promotes β-sheet structure formation by Aβ
peptides, which will imply β-barrel-like pore formation in lipid membranes. This effect is
expected to be more pronounced for the hypertoxic peptide species, i.e., pEAβ3-42 and pEAβ3-40.
In addition, β-barrel pore formation is expected to be facilitated by physiological temperature of
37⁰C as compared to the “room temperature” of 20⁰C.
13

Hypothesis: If Aβ shows that 1. it has β-barrel characteristics in exposure to aqueous
environment and 2. embeds itself into lipid membranes, then it is likely that Aβ induces
membrane pore formation, leading to neurotoxic effects in AD.
Overall, the collected data will highlight the conformational changes that Aβ peptides
undergo in cell membranes, leading to a more thorough understanding of Aβ's role in pore
formation and the peptide’s mechanism of neurotoxic action in Alzheimer’s Disease. The
uncovered structure of the Aβ-lipid complex may also be important to design new therapeutic
techniques and can supplement further experimentation.
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Chapter 3

MATERIALS AND METHODS
I.

Materials

The peptides, Aβ1-42 and Aβ1-40 were purchased from rPeptide. pEAβ3-42 and pEAβ3-40 were
purchased from Innovagen (Sweden). The lipids 1-palmitoyl-2-oleyl-sn-glycero-3phosphocholine (POPC), 1-palmitoyl-2-oleyl-sn-glycero-3-phosphoglycerol (POPG), and
cholesterol were purchased from Avanti Polar Lipids, Inc. (Albaster, AL). The polycarbonate
filters used for extrusion were purchased from Avestin, Inc. (Ottawa, Ontario, Canada). The
Germanium plate used in ATR-FTIR technique was purchased from Spectral Systems (Irvington,
NY). Organic solvents (chloroform, hexafluoroisopropanol (HFIP), methanol), salts, buffers and
other chemicals were purchased from Sigma-Aldrich or Fisher Scientific.

Figure 3.1: The chemical structures of cholesterol (left), POPC (top right), and POPG (bottom right). Reference:
Avanti Polar Lipids

II.

Methods
Synthetically derived Aβ peptide (of 4 various species previously mentioned) were

implanted into lipid membranes consisting of 60% POPC, 30% POPG, and 10% cholesterol. 25
mM NaCl plus 25 mM NaCl plus 25mM Na,K-phosphate buffer at pH 7.2 were used as the
15

solvent during spectroscopic measurement. In FTIR experiments, D2O was used because H2O
absorbs in the amide I spectral region where the peptide’s structure is analyzed. CD, fluorescence
and light scattering measurements was taken at both 20°C and 37°C (room and body
temperature, respectively). Fluorescence measurements was taken with excitation at 220 nm and
275 nm. FTIR experiments were conducted at ambient temperature, i.e. 20⁰C.
The following Table identifies the various roles the spectroscopic techniques have in
studying the structure of the peptide:

Table 3.1: The various roles of the spectroscopic techniques.
CD
2⁰ structure

Fluorescence
3⁰ structure

3⁰ structure

Light
Scattering
Presence of
vesicles in
suspension

FTIR

ATR-FTIR

2⁰ structure

All that applies
to FTIR plus
orientation of
membrane
proteins and
lipid structural
order

3⁰ structure
Effect of peptide
on structure of
membrane lipids

Further details are discussed below in each technique’s respective section.

Circular dichroism (CD)
CD is a valuable technique in structural biology. It uses circularly polarized light to
measure the ellipticity (the difference of absorption of left- and right-handed circularly polarized
light) of optically active molecules (in this case, the Aβ peptide). Ellipticity is calculated with the
equation ∆𝐴 = 𝐴𝐿 − 𝐴𝑅 , where A equals absorbance and L and R equal left and right circularly
polarized light, respectively. Data is reported as either differential absorbance (ΔA) or in
16

ellipticity (degrees) [θ]. The spectrum measures dichroism as a function of wavelength. CD is
used to observe the secondary structure of proteins (α, β, β-turn, and unordered structure).
Different secondary structures generate positive or negative CD bands at characteristic
wavelengths thus creating unique spectra features, which allows evaluation of the protein’s or
peptide’s structure from spectral analysis. Spectral bands can be assigned to various structural
features because signals only occur where radiation is absorbed. CD measurements were
conducted on a J-810 spectropolarimeter equipped with a fluorescence attachment and a
temperature controller (Jasco, Tokyo, Japan). Measurements were taken between 180 nm and
360 nm wavelengths.

Figure 3.2: Linear vs. Circularly polarized light

Fourier-transform infrared spectroscopy (FTIR)
FTIR is a type of vibrational spectroscopy widely used to analyze protein structure and
dynamics. Oscillating dipoles caused by change in internuclear distance or geometry absorb the
energy of the incident light. Different chemical groups have vibrations at specific frequencies, so
they absorb in different regions of the IR spectrum. FTIR spectra of proteins contain absorbance
bands of different structural or functional groups in the mid-IR region, i.e. 4000 cm-1 to 400 cm-1,
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where the unit cm-1 simply implies the inverse of the wavelength. Specifically, protein structure
is determined by analyzing the amide I and amide II bands. The amide I band (1700-1600 cm-1)
reveals information about the protein’s secondary structure. The amide II band (around 15601530 cm-1) is sensitive to solvent accessibility and protein’s tertiary structure. Using FTIR, the
overall secondary and tertiary structures of Aβ peptides can be analyzed. FTIR studies were done
using a Vector-22 FTIR spectrometer (Bruker Optics, Billerica, MA, USA) equipped with a
liquid nitrogen-cooled Hg-Cd-Te detector.

Attenuated Total Reflection (ATR)-FTIR
ATR-FTIR is a useful technique in studying membrane proteins and lipids, proteinmembrane interactions, interactions of proteins with drugs, nucleic acids, the structural features
of membrane pore forming proteins, and much more. In an ATR-FTIR experiment, the incident
infrared light is shone through an internal reflection element (IRE), such as a germanium crystal
plate, coated with sample (in this case, Aβ embedded into lipid membrane). The incident light
enters the Ge plate through an edge cut at 45 degrees and undergoes a series of total internal
reflections, thereby bounces through the crystal until it exits the plate at the other edge and is
directed to the detector. At each reflection, an evanescent wave is created outside the Ge plate,
allowing the sample deposited on the surface of the plate to absorb part of the light (see Figure
3.3). This way the absorbance spectrum of the sample is recorded as the intensity of the light
reaching the detector is less than that of the incoming light. Information about the sample is
gathered through the interaction between the wave and the sample and eventually gets shone
onto the detector.
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This experiment used both parallel and perpendicular polarized light to characterize Aβ’s
orientation and structure in the lipid membrane. Polarized ATR-FTIR is especially beneficial in
comparison to other FTIR techniques due to its heightened sensitivity and its capability of
determining the orientation of membrane bound proteins. Some of the benefits of using ATRFTIR over other FTIR techniques is that a) small amount of sample can be used to obtain strong
signal, and b) the orientation of the peptide can be determined in addition to its secondary and
tertiary structures.

Figure 3.3: ATR-FTIR setup. The grey trapezoid is an internal reflection element (IRE) covered with lipid
membranes embedded with proteins. Mirrors (M1-4) direct the incident light through the IRE and into the detector.
Reference: (Tatulian, 2019).

Fluorescence
Fluorescence spectroscopy has been widely used in structural biology to study proteins.
Fluorescence measures the emission of photons by atoms after being excited with UV or visible
radiation. When excited with this form of radiation, fluorescent substances (fluorophores) absorb
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photons by means of transition of electrons from low (ground) to high (excited) energy levels,
then within about 10 ns they return to the ground state and emit photons at lower energy,
corresponding to lower frequency and longer wavelength. Part of the energy is lost to the solvent
through a process known as solvent relaxation, i.e. reorientation of polar solvent molecules by
the dipole moment created by electron transitions. More specifically, fluorescence takes
advantage of the intrinsic fluorophores tryptophan, tyrosine, and phenylalanine, which contain an
indole, phenol, or benzyl aromatic rings, respectively. These aromatic groups absorb between
260 nm and 280nm and emit between 290 nm and 340nm. Lipid membranes are not typically
fluorescent. Fluorescence data is presented as an emission spectrum, i.e., a plot of emission
intensity vs. wavelength. Fluorescence measurements were taken with excitation at 220 and 275
nm wavelengths using a J-810 spectropolarimeter with fluorescence attachment.

Light scattering
Light scattering occurs when polar or charged groups of molecules or larger particles
oscillate and emit radiation when exposed to electromagnetic radiation, including UV or visible
light. As the intensity of emission is proportional to the particle size, light scattering can be used
to measure particle size, protein-protein interactions, protein-membrane interactions, among
other things. Based on this principle, the presence of lipid vesicles, which are ~50 times larger
than the Aβ peptides, were observed by this method. Light scattering was done using the same J810 spectropolarimeter in fluorescence mode, using incident light at large wavelengths, such as
550 nm, to avoid fluorescence emission.
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Vesicle preparation
Three lipids were used to prepare unilamellar vesicles: a zwitterionic lipid (POPC), an
anionic lipid (POPG), and cholesterol.

A. Vesicle Preparation for CD and Fluorescence:
A mixture of 74.83 µL of 2.00 mM POPC, 37.50 µL of 2.00 mM POPG, 12.50 µL of 2.00
mM cholesterol, and 25.00 µL of 200 µM peptide were combined in a vial, dried with a stream
of N2 gas, and desiccated for 15 minutes. 500 µL of 25 mM NaCl + Na,K-phosphate buffer (pH
7.2) was added to sample, vortexed for 5 minutes, extruded through a 0.1µm Nuclepore
polycarbonate membrane 15 times, and collected in a fresh vial. This results in following final
lipid and peptide concentrations: 300 µM POPC, 150 µM POPG, 50 µM cholesterol, 10 µM
peptide, with total lipid to peptide molar ratio of 50:1. The membrane lipid composition is 60%
POPC, 30% POPG, 10% cholesterol.

B. Peptide-Lipid Sample Preparation for ATR-FTIR:
A mixture of 18.75 µL 20 mM POPC, 9.375 µL 20 mM POPG, 3.125 µL 20 mM cholesterol,
dissolved in chloroform, and 62.5 µL 200 M peptide dissolved in HFIP, were combined in a
vial, spread onto a Ge plate, and dried via desiccation for 1h before assembly into a flow-through
ATR sample cell. FTIR spectra of the peptide-lipid sample, which make a multilayer on the Ge
plate, were measured at parallel and perpendicular polarizations of the incident infrared light.
Buffer were injected, allowing full hydration of the sample, and spectra at both polarizations
were measured. These measurements have allowed determination of peptide structure and
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orientation in lipid membranes (see Chapter 4), in both dehydrated and fully hydrated states,
which leads to construction of a structural model of membrane pores formed by Aβ peptides.

Data Analysis
The orientation of the pore was measured by the β-angle, or the angle between beta
strands and the barrel’s central axis (as indicated by Eq (5) in Chapter 4). The angle was
measured based on an axis perpendicular to the lipid membrane. Meaningful angles align with
0⁰, as this means that the channel is completely open on both sides. The angles 0⁰ and 20⁰ were
used for the angle of barrel axis relative to the membrane normal during calculations.
Lipid order parameter is another measurement that was considered. This measurement
determines how ordered the lipid membrane is, which denotes quality of the lipid bilayer. A lipid
order parameter of 0 indicates that there is no bilayer and that the lipids are randomly dispersed
throughout the sample, while increasing numbers indicate higher order of bilayers. This is
important to consider when studying ion channels because it reveals whether the channel disrupts
the membrane order or not.
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CHAPTER 4

RESULTS
CD Experiments
For initial structural characterization of A peptides in aqueous buffer and reconstituted
in lipid membranes, CD spectra were measured at 20oC and 37oC. These temperatures were
chosen for two reasons. Measurements at 20oC were conducted to directly compare CD data with
FTIR data, as the FTIR spectrometer does not have a temperature controller and can be used at
ambient temperature, i.e. 20oC 1oC, and measurements at 37oC were conducted to mimic
physiological conditions. Far-UV CD spectra of A1-42 in aqueous buffer generated a deep
minimum at 218-220 nm at both temperatures, indicating formation of -sheet structure (Figure
4.1). CD spectra

Figure 4.1: Circular dichroism spectra of A1-42 in aqueous buffer (25 mM NaCl, 25 mM Na,K-phosphate, pH 7.2)
and reconstituted in unilamellar lipid vesicles composed of 60 mol % POPC, 30 mol % POPG, and 10 mol %
cholesterol, as indicated, at 1:50 peptide/lipid molar ratio. Blue and red lines correspond to 20 oC and 37oC,
respectively.
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of A1-42 in reconstituted in unilamellar lipid vesicles composed of 60 mol % POPC, 30 mol %
POPG, and 10 mol % cholesterol display deeper minima at 215-216 nm, again indicating
formation of -sheet structure. The blue-shifted CD bands of the peptide in membranes suggest
twisting of -strands to a larger degree (Wang et al. 2016). Twisted -strands are typical for barrel protein structures, which form pores in cell membranes. Thus, CD data suggest formation
of -barrel-like structure by A1-42 in lipid membranes.

Fluorescence Experiments
A1-42 has fluorescence properties due to the presence of one tyrosine (Tyr) at position 10
and three phenylalanines (Phe) at positions 4, 19, 20. Hence, fluorescence spectroscopy was used
to see whether the emission wavelength and/or intensities of these fluorophores change upon
incorporation of the peptide in lipid membranes. Both Tyr and Phe can be excited in a wide
range of UV radiation, and their emission peaks occur around 310 nm and 287 nm, respectively.
It has been identified that Phe can be predominantly excited at 220 nm, whereas Tyr can be
selectively excited at 275 nm; both excitation wavelengths were used in this analysis.
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Figure 4.2: Fluorescence spectra of Ab1-42 in aqueous buffer (25 mM NaCl, 25 mM Na,K-phosphate, pH 7.2) and
reconstituted in unilamellar lipid vesicles composed of 60 mol % POPC, 30 mol % POPG, and 10 mol %
cholesterol, as indicated, at 1:50 peptide/lipid molar ratio. Excitation was at 220 nm (A) or at 275 nm (B). Blue and
red lines correspond to 20oC and 37oC, respectively. Fluorescence emission peaks occur at 310 nm for the peptide
either in buffer or in vesicle membranes when excited at 220 nm (A). Upon excitation at 275 nm, emission peaks
occur at 307 nm at 20oC and at 310 nm at 37oC for the peptide in buffer and at 308 nm for the peptide in vesicle
membranes.

Excitation at 220 nm resulted in relatively sharp emission peaks at 310 nm for A1-42 in
buffer or in vesicle membranes, with higher intensity in the latter case (Figure 4.2A). This
finding indicates that a) Tyr fluorescence obscures that of Phe due to a greater quantum yield
(Lakowicz, 1999), and b) the peptide is inserted into the membrane, which protects from
fluorescence quenching by water (Li et al., 2011). Stronger signal at 220 nm in the presence of
vesicles results from light scattering. Upon excitation at 275 nm, again Tyr emission is detected
between 307 nm and 310 nm, with significantly stronger fluorescence signal and stronger scattering
of incident light in the presence of vesicles (Figure 4.2B). In all cases, the fluorescence intensity
decreases at higher temperature (37oC), as expected (Lakowicz, 1999). Thus, CD and fluorescence
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data suggest that A1-42 does insert into lipid vesicle membranes and adopts -sheet structure
with twisted strands.

Light Scattering Experiments
To obtain additional documentation for the presence of lipid vesicles, light scattering
measurements were conducted on same A and A/membrane samples in parallel with CD and
fluorescence measurements. Large wavelength (550 nm) for light scattering was chosen to avoid

Figure 4.3: Light scattering at 90 degrees of A1-42 in aqueous buffer (25 mM NaCl, 25 mM Na,K-phosphate, pH
7.2) and reconstituted in unilamellar lipid vesicles composed of 60 mol % POPC, 30 mol % POPG, and 10 mol %
cholesterol, as indicated, at 1:50 peptide/lipid molar ratio, at 20 oC.

fluorescence effects. As expected, light scattering intensity was much stronger in the presence of
vesicles as compared to the A1-42 peptide in buffer (Figure 4.3).
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ATR-FTIR Experiments
The main information on secondary structure and orientation of the peptides relative to
the membrane was obtained from ATR-FTIR experiments. These experiments were conducted
on peptide-lipid samples in dry state and after addition of aqueous buffer, at 1:50 peptide/lipid
molar ratio. The meaning of studying dehydrated (dry) samples is to mimic the A peptide as the
transmembrane part of APP, before cleavage and exposure to the aqueous environment. It is
known that the A stretch in the context of APP is mostly in -helical conformation (Barrett et
al. 2012) and when cleaved and released into the aqueous medium, acquires -sheet structure.
ATR-FTIR spectra were measured at parallel (II) and perpendicular (⊥) polarizations of the
incident light, and peak-fitting was applied to identify the spectral components in the lipid C=O
and peptide amide I and amide II regions. The overall areas of all components were then
determined using both II and ⊥ spectra as follows: ai = ai,II + Gai⊥, where ai is the area of the i-th
component and G is a scaling factor, which for present experimental conditions is G = 1.44
(Tatulian, 2019; Tatulian et al., 2012). The fractions of -helix, -sheet, turn (t), and unordered
() structures were calculated using the amide I areas of respective components and their
extinction coefficients, , as described earlier (Tatulian, 2019):

𝒇𝒊 =

𝒂𝒊
𝒂𝜶 𝒂𝜷 𝒂𝒕 𝒂𝝆
𝜺𝒊 ( + + + )
𝜺𝜶 𝜺𝜷 𝜺𝒕 𝜺𝝆

(1)

Previously determined values for the extinction coefficients have been used:  = 7.6107
cm/mol,  = 6.2107 cm/mol, t = 5.5107 cm/mol,  = 4.5107 cm/mol (Venyaminov &
Kalnin, 1990). The assignment of amide I components to secondary structure types was done
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according to established wavenumber ranges for various protein structures, i.e., turn structures:
1705-1661 cm-1, -helix: 1660-1646 cm-1, unordered: 1645-1638 cm-1, -sheet: 1637-1625 cm-1
(Tatulian, 2019). Amide I components below 1620 cm-1 were assigned to side chains.

Figure 4.4: ATR-FTIR spectra of A1-42 reconstituted in lipid multilayers composed of 60 mol % POPC, 30 mol %
POPG, and 10 mol % cholesterol at 1:50 peptide/lipid molar ratio, dehydrated by desiccation, at parallel (A) and
perpendicular (B) polarizations of the incident light. The measured spectrum is shown in solid line colored cyan, and
the fitted curve (curvefit) is shown as black dotted line. Spectral components in lipid C=O, amide I and amide II
regions are presented as follows: lipid C=O components: black dashed lines; turn structures: solid grey lines; helix; solid green line; unordered: solid blue line; -sheet: solid red line; side chains: solid brown line; amide II
components: solid black lines. Panel C shows the dichroic spectrum, i.e., the ratio of spectra at II and ⊥ polarizations.

Data presented in Figure 4.4A,B show that in dry peptide/lipid samples, A1-42 acquires a
combination of -helix and -sheet structures, as indicated by green and red amide I
components. The wavenumbers of all amide I structural components, their fractions, and the
respective numbers of amino acids for all four peptides in dry state and when hydrated by buffer
are presented in Table 1. Data of Table 1 indicate -helical and -sheet fractions in A1-42 in dry
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state f = 0.24 (10 amino acid residues) and f = 0.30 (12.6 amino acid residues). A significant
fraction of turn structure (ft = 0.41) and a negligible fraction of unordered structure (fr = 0.052)
are also present.

Table 4.1: Amide I wavenumbers (), fractions (f), and numbers of amino acid residues (N) for
-helix, -sheet, turn (t), and unordered () structures derived from ATR-FTIR spectra.
A1-42

 (cm-1)

pEA3-42

A1-40

pEA3-40

Dry

Buffer

Dry

Buffer

Dry

Buffer

Dry

Buffer

1658

16591657 a)

16581655

16511646

16601658

16561654

16581655

16521651

16661663 b)
f

0.24

0.20

0.20

0.25

16681666 b)
0.20

0.15

0.22

0.08 b)



10.0

8.5

8.0

10.0

0.20
0.13 b)

8.0

6.0

8.3

3.2 b)

7.6
5.0 b)

 (cm-1)

16321630

1627

16331630

1628

16311629

1629

16311630

16271625

f

0.30

0.44

0.26

0.37

0.21

0.17

0.26

0.27



12.6

18.2

10.4

14.8

8.4

6.8

10.0

10.3
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t (cm-1)

17001671

17001678

17011669

16991678

17041672

17051669

16981668

17001681

ft

0.41

0.16

0.48

0.30

0.46

0.55

0.45

0.22

t

17.2

6.9

19.2

12.0

18.4

22.0

17.0

8.4

 (cm-1)

1645

16431642

1645

N/A

16451643

16421640

16461642

16391637

f

0.052

0.20

0.06

0.00

0.13

0.13

0.07

0.18



2.2

8.4

2.4

0.00

5.2

5.2

2.7

6.7

a) Wavenumbers of ⊥ spectra are usually slightly lower than those of II spectra.
b) These components have been assigned to II-helix

The orientational order parameter of -helical structure was determined using the formula
(Tatulian, 2003):
𝟐𝑩

𝑺 = (𝟑𝒄𝒐𝒔𝟐 𝜶−𝟏)(𝑩−𝟑𝑬𝟐 )

(2)

𝒛

In Eq. (2), 𝐵 = 𝐸𝑥2 − 𝑅𝐸𝑦2 + 𝐸𝑧2 ,  is the angle between the transition dipole moment and
the molecular axis (for -helix,  = 39o1o), Ex = 1.399, Ey = 1.514, and Ez = 1.621 are the
electric vector components of the evanescent wave, and R is the dichroic ratio, i.e. R = aII/a⊥.
Values of R for -helix have been determined from the dichroic spectrum (Figure 4.4C) and
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used to calculate the helical order parameter. The angle of orientation of helical axis relative to
the membrane normal, , was calculated from the order parameter through:

2𝑆+1

𝑐𝑜𝑠𝜃 = √

(3)

3

The orientation of -strands can be determined from -sheet dichroic ratio of a protein or
a peptide that adopts a structure with a rotational axis of symmetry, such as a -barrel. Then, the
following relationship holds:
𝟏
𝟐

(𝟑𝒄𝒐𝒔𝟐 𝜹 − 𝟏) =

𝟐𝑩

(4)

(𝟑𝒄𝒐𝒔𝟐 𝜸−𝟏)(𝑩−𝟑𝑬𝟐𝒛 )

In Eq. (4),  is the angle of the transition dipole moment of β-strands with respect to the
central axis, and γ is the tilt angle of the central axis of the barrel structure with respect to the
membrane normal. The amide I transition dipole is oriented perpendicular to the -strand axis,
which yields the following relationship between angle  and the angle  of orientation of the
strand axis relative to the barrel’s central axis:
𝝅

𝜹= 𝟐−𝜷

(5)

The angle  for the proposed barrel structure could be determined through Eqs. (4) and
(5) using the measured dichroic ratio for the -sheet component of the amide I spectrum (Figure
4.4C) if the angle  was known. In a situation when  is not known, a practically useful approach
is to assume conceivable values, such as  = 0 degrees or  = 20 degrees, and determine the
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orientations of strands in a -barrel. This approach has been used here. The resulting
orientational parameters, along with -helical and -sheet dichroic ratios, are summarized in
Table 4.2.
Table 4.2: Dichroic ratios and orientational angle for -helical and -sheet components of the
peptides in dehydrated state and under aqueous buffer.
Dry
 (o)

R

Under buffer
R

( )

 (o)

R

R

o

 = 0o

 =20o

 = 0o

 =20o

 (o)

A1-42

1.393

25.9

23.6

1.837

59.9

1.710

31.4

30.6

1.699

65.2

pEA3-42

1.456

27.1

25.2

1.458

80.7

2.273

38.2

38.8

2.225

48.8

2.041a) 53.6 a)
A1-40

1.415

26.3

24.2

1.773

62.2

1.931

34.4

34.2

1.844

59.6

pEA3-40

1.428

26.6

24.5

1.821

60.5

1.757

32.1

31.4

1.916

57.3

1.952 a 56.2 a)
a) These spectra display components that can be assigned to II-helix, see Table 1 for their
wavenumbers.

Data of Table 4.2 indicate strand tilt angle of around 25 degrees for A1-42 in dehydrated
state. This result is consistent with earlier data on the A25-35 fragment reconstituted in supported
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lipid layers of similar lipid composition, where -strands were tilted by 224 degrees from the
barrel axis (Kandel et al., 2019). In case of a Bax protein-derived peptide, the proposed -barrel
was characterized with strand tilt angles between 20 and 30 degrees (Tatulian et al., 2012), again
in agreement with current data. It is noteworthy that the value of angle  varies within only 2.5
degrees when  changes from 0 to 20 degrees, indicating the validity of this approach. The
orientation of the helical part of A1-42 in dehydrated membranes is around 60 degrees (Table
4.2). It is conceivable that the N-terminal polar part of the peptide forms -helical structure that
lies obliquely on the membrane surface whereas the more hydrophobic C-terminal half embeds
into the membrane in the form of -strands and assembles into a -barrel structure.

Figure 4.5: ATR-FTIR spectra of A1-42 reconstituted in lipid multilayers composed of 60 mol % POPC, 30 mol %
POPG, and 10 mol % cholesterol, totally hydrated by a D 2O-based buffer (25 mM NaCl, 25 mM Na,K-phosphate,
pD 7.2), at parallel (A) and perpendicular (B) polarizations of the incident light. Significance of line type and color
is described under Figure 4.4. Panel C shows the dichroic spectrum, i.e., the ratio of spectra at II and ⊥ polarizations.

Significant structural transitions occur when an aqueous buffer is injected into the sample
cell containing the supported peptide/lipid system (Figure 4.5). First, the presence of the buffer is
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manifested by the shift of the lipid C=O band’s components. The lipid carbonyl group stretching
vibration generates absorbance band with two components at 1742 cm-1 and 1728 cm-1, where
the higher and lower wavenumber components correspond to dehydrated and hydrated C=O
groups; H-bonding with water weakens the C=O covalent bond and thereby decreases the
vibrational frequency (Blume et al., 1988). Comparison of data in Figures 4.4A,B and 4.5A,B
show substantial increase of the low frequency component and decrease of the high frequency
component in the presence of buffer. Second, addition of D2O-based buffer initiates amide
hydrogen/deuterium exchange, which results in a shift of the amide II band from ~1550 cm-1 to
~1450 cm-1 (the amide II region is not shown in Figure 4.5 because it becomes too noisy). Most
importantly, the fraction of -sheet structure of the peptide increases from 30% to 44% mostly at
the expense of turn and -helix structures, which decline from 41 % to 16% and from 24% to
20% respectively (Figure 4.5 and Table 4.1). Finally, the orientation of -strands becomes more
tilted (  31 degrees) and the -helical axis tilt angle goes from 60 to 65 degrees. The -strand
tilt just above 30 degrees is similar to the respective angle of mitochondrial and bacterial porins,
which form canonical -barrel structure (Páli and Marsh, 2000; Kleinschmidt, 2006; Zeth and
Thein, 2010), lending additional support for our conjecture that A1-42 forms -barrel structure in
lipid membranes.
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Figure 4.6: ATR-FTIR spectra of pEA3-42 reconstituted in lipid multilayers composed of 60 mol % POPC, 30 mol
% POPG, and 10 mol % cholesterol, in dehydrated state, at parallel (A) and perpendicular (B) polarizations of the
incident light. Significance of line type and color is described under Figure 4.4. Panel C shows the dichroic
spectrum, i.e., the ratio of spectra at II and ⊥ polarizations.

The pyroglutamylated peptide pEA3-42 reconstituted in supported membranes exhibits
structural properties resembling those of its unmodified counterpart. In dehydrated state, the
peptide displays 20% -helix, 26% -sheet, 48% turn, and 6% unordered structure (Figure 4.6,
Table 4.1). Addition of buffer increases the fraction of -sheet to 37% and that of -helix to
25%, while the turn structure declines to 30% and the unordered structure becomes negligible
(Figure 4.7, Table 4.1). Interestingly, in the hydrated sample an amide I component emerges in
the 1666-1663 cm-1 region, which has been assigned to II-helix, i.e. a helical structure with
identical geometry to the regular a-helix but with slightly tilted amide plane and with weaker
helical H-bonding (Torres et al. 1995; Wang and El-Sayed, 2000). This II-helical structure
constitutes around 8% (3.2 amino acid residues, i.e. barely 1 helical turn) of the peptide and is
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likely to be located at the edges of the regular -helix.

Figure 4.7: ATR-FTIR spectra of pEA3-42 reconstituted in lipid multilayers composed of 60 mol % POPC, 30 mol % POPG,
and 10 mol % cholesterol, totally hydrated by a D2O-based buffer (25 mM NaCl, 25 mM Na,K-phosphate, pD 7.2), at parallel
(A) and perpendicular (B) polarizations of the incident light. Significance of line type and color is described under Figure 4.4,
except that the proposed II-helix component is colored orange. Panel C shows the dichroic spectrum, i.e., the ratio of spectra at II
and ⊥ polarizations.

The orientation of -strands of pEA3-42 in dry state is similar to that of Aβ1-42, but in
hydrated state becomes more tilted, i.e.  = 38-39 degrees (Table 4.1). This tilt angle is still in
the range of strand tilts of β-barrel porins in mitochondrial and bacterial membranes (Páli and
Marsh, 2000; Kleinschmidt, 2006; Zeth and Thein, 2010). The -helix in dry state is more
inclined to the membrane surface in dry state ( = 81 degrees) and less tilted when hydrated with
buffer ( = 49 degrees). The orientation of the II-helix is similar to that of the regular -helix,
as expected.
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Figure 4.8: ATR-FTIR spectra of A1-40 reconstituted in lipid multilayers composed of 60 mol % POPC, 30 mol %
POPG, and 10 mol % cholesterol, in dehydrated state, at parallel (A) and perpendicular (B) polarizations of the
incident light. Significance of line type and color is described under Figure 4.4. Panel C shows the dichroic
spectrum, i.e., the ratio of spectra at II and ⊥ polarizations.*

Aβ1-40 exhibited much milder signal than Aβ1-42 and pEAβ3-42. This is potentially caused
by it being more hydrophilic, which may have caused a little bit of the sample volume to be
washed away when buffer was added and may contribute to a decreased pore-forming capability.
In a dehydrated state, Aβ1-40 peptide displays 20% α-helix (8 amino acid residues), 21%
β-sheet (8.4 amino acid residues), 46% turn (18.4 amino acid residues), and 13% unordered
structure (5.2 amino acid residues) (Figure 4.8, Table 4.1). After the addition of buffer, structural
composition changes to 15% α-helix (6 amino acid residues), 17% β-sheet (6.8 amino acid
residues), 55% turn (22 amino acid residues), and 13% unordered structure (5.2 amino acid
residues).
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Figure 4.9: ATR-FTIR spectra of A1-40 reconstituted in lipid multilayers composed of 60 mol % POPC, 30 mol % POPG, and
10 mol % cholesterol, totally hydrated by a D2O-based buffer (25 mM NaCl, 25 mM Na,K-phosphate, pD 7.2), at parallel (A)
and perpendicular (B) polarizations of the incident light. Significance of line type and color is described under Figure 4.4, except
that the proposed II-helix component is colored orange. Panel C shows the dichroic spectrum, i.e., the ratio of spectra at II and ⊥
polarizations.

The orientation of β-strands of Aβ1-40 in a dry state is about 25 degrees (Table 4.2), and in
a hydrated state is about 34 degrees (Table 4.2). This angle is consistent with the strand tilts of
mitochondrial and bacterial β-barrel porins (Páli and Marsh, 2000; Kleinschmidt, 2006; Zeth and
Thein, 2010). The α-helix tilt angle goes from 62.2 to 59.6 degrees in exposure to buffer.
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Figure 4.10: ATR-FTIR spectra of pEA3-40 reconstituted in lipid multilayers composed of 60 mol % POPC, 30 mol
% POPG, and 10 mol % cholesterol, in dehydrated state, at parallel (A) and perpendicular (B) polarizations of the
incident light. Significance of line type and color is described under Figure 4.4. Panel C shows the dichroic
spectrum, i.e., the ratio of spectra at II and ⊥ polarizations.

The pyroglutamylated peptide pEAβ3-40 exhibits less structural similarity to Aβ1-40 than
pEAβ3-42 does to its unmodified counterpart. This could be due to the fact that pEAβ3-40 is less
hydrophilic than Aβ1-40. In a dehydrated state, pEAβ3-40 peptide displays 22% α-helix (8.3 amino
acid residues), 26% β-sheet (10 amino acid residues), 45% turn (17 amino acid residues), and 7%
unordered structure (2.7 amino acid residues) (Figure 4.10, Table 4.1). After the addition of
buffer, structural composition changes to 20% α-helix (7.6 amino acid residues), 27% β-sheet
(10.3 amino acid residues), 22% turn (8.4 amino acid residues), and 18% unordered structure
(6.7 amino acid residues).
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Figure 4.11: ATR-FTIR spectra of pEAβ3-40 reconstituted in lipid multilayers composed of 60 mol % POPC, 30 mol
% POPG, and 10 mol % cholesterol, totally hydrated by a D 2O-based buffer (25 mM NaCl, 25 mM Na,K-phosphate,
pD 7.2), at parallel (A) and perpendicular (B) polarizations of the incident light. Significance of line type and color
is described under Figure 4.4, except that the proposed a II-helix component is colored orange. Panel C shows the
dichroic spectrum, i.e., the ratio of spectra at II and ⊥ polarizations.

The orientation of β-strands of pEAβ3-40 in a dry state transitioned from about 25 degrees to
about 34 degrees after exposure to buffer. Like Aβ1-40, pEAβ3-40 exhibited strand tilts consistent
with mitochondrial and bacterial β-barrel porins (Páli and Marsh, 2000; Kleinschmidt, 2006;
Zeth and Thein, 2010). The α-helix is 60.5 degrees in a dehydrated state and changes to 57.3
degrees when hydrated with buffer.
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Effect of Aβ peptide on lipid membranes
If the peptides form -barrel structure in lipid membranes, they may affect the structural
order of the lipid hydrocarbon chains. To test the effect of the peptides on lipid structure, the
order parameter of lipid acyl chains in supported membranes has been determined without added
peptide and in the presence of each of the four A peptides, in dehydrated and hydrated states.
This was accomplished by analysis of the ATR-FTIR spectral region corresponding to methylene
(CH2) stretching vibrations. The CH2 groups of lipid acyl chains undergo asymmetric and
symmetric stretching vibrations and generate absorbance bands at wavenumbers around 2920
cm-1 and 2850 cm-1, respectively (Tatulian 2003) (Figure 4.12). For a hydrocarbon chain in alltrans configuration, the transition dipole moment of CH2 vibrations is oriented perpendicular to
the chain axis. Therefore, the order parameter of lipid acyl chains (SL) can be determined through
Eq. (2) using  = 90o. Dichroic ratios have been determined as RL = aL,II /aL,⊥, where aL,II and aL,⊥
are the total areas of lipid CH2 absorbance bands from 3015 cm-1 to 2810 cm-1.
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Figure 4.12: (A): ATR-FTIR spectra of a supported lipid multilayer composed of 60 mol % POPC, 30 mol %
POPG, and 10 mol % cholesterol, in dry state (blue) or hydrated by a D2O-based buffer of 25 mM NaCl, 25 mM
Na,K-phosphate, pD 7.2 (green), at parallel (solid) and perpendicular (dotted) polarizations of the incident light. (B):
Same with reconstituted peptide Ab1-42 at peptide/lipid molar ratio of 1:50.
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Table 4.3: Lipid acyl chain dichroic ratios (RL), order parameters (SL), and peak wavenumbers of
asymmetric and symmetric vibrations of methylene groups (asym, sym) in the absence and
presence of four A peptides.
Plain lipid

A1-42

pEA3-42

A1-40

pEA3-40

Dry

Buff.

Dry

Buff.

Dry

Buff.

Dry

Buff.

Dry

Buff.

RL a)

1.501

1.379

1.451

1.267

1.568

1.394

1.537

1.430

1.524

1.463

SL

0.340

0.441

0.380

0.542

0.287

0.428

0.311

0.397

0.321

0.370

asym

2921.1

2922.0-

2922.6-

2923.0-

2923.0-

2923.0-

2923.0-

2924.0-

2923.0

2924.0-

2921.1

2921.6

2922.0

2922.0

2922.0

2922.0

2923.0

2852.6-

2852.2

2852.6-

2852.6

2852.6

2852.6

2853.6-

(cm-1)b)
sym

2851.6

(cm-1) b)

2851.6

2851.6

2923.0
2852.6

2852.6

2852.6

a) Dichroic ratios based on total areas between 3015 cm-1 and 2810 cm-1.
b) Wavenumbers at perpendicular polarization are lower by ~1 cm-1 compared to those at
parallel polarization,

Data on lipid dichroic ratios, order parameters, and peak wavenumbers of asymmetric and
symmetric modes of stretching vibrations are summarized in Table 4.3. As seen from Table 4.3,
the order parameter of plain lipid without any peptide is 0.34 in dry state and 0.44 under aqueous
buffer. For all-trans hydrocarbon chains oriented strictly perpendicular to the Ge plate, a limiting
value of SL = 1 is expected, and for totally unordered chains, SL = 0. Taking into account that
both POPC and POPG contain a double bond in their sn-2 acyl chains, which adopts cis
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configuration and thereby causes significant orientational disorder, these order parameters (0.340.44) indicate reasonably well-organized membranes. For comparison, the order parameter of
POPC monolayers on Ge plate was 0.05, and that of dipalmitoyl-phosphatidylcholine, a lipid
with saturated acyl chains, was 0.7 (Tatulian, 2003). In other studies on POPC/POPG supported
membranes, SL values have been reported in the range between 0.3 and 0.7. The wavenumbers of
asymmetric and symmetric CH2 stretching vibrations occur around 2921 cm-1 and 2852 cm-1.
CH2 stretching wavenumbers are sensitive to the physical state of lipids and undergo increase
from ~2916 cm-1 to ~2924 cm-1 upon thermal transition from sold state to fluid state
(Mendelsohn and Mantsch, 1986; Mantsch and McElhaney, 1991). Wavenumbers presented in
Table 4.3 indicate a fluid-like state of supported membranes, which is due to the unsaturated
bonds in POPC and POPG and reasonably models the properties of biological membranes.
The presence of peptides in the membranes exerts nontrivial effects on lipid order. In both dry
state and under aqueous buffer, A1-42 increases the lipid order whereas the other three peptides
decrease SL (Table 3). This finding suggests a unique property of A1-42 compared to the other
peptides, which may be related to its ability to form ion-conducting pores in membranes. For
example, formation of ion channels in plasma membranes of HEK cells has been reported for
A1-42 oligomers, whereas A1-40 failed to form channels in any aggregation state (Bode et al.
2017). Data on membrane pore forming abilities of all A species studied in this work will be
required to answer questions about the mechanisms of their differential cytotoxic effects.
However, current data provide important information of the structural aspects of interaction of
these peptides with membranes and lay groundwork for further studies and discoveries.
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Chapter 5

DISCUSSION

Summary
Overall, results indicate that Aβ-induced pore formation is highly plausible. This can be
concluded with the evidence of β-barrel structure and the peptide’s insertion into the lipid
membrane.
CD data suggest formation of β-barrel-like structure by Aβ1-42 in lipid membranes. Aβ in
membranes exhibited a blue-shifted spectrum in comparison to Aβ free-floating in buffer,
suggesting twisting of β-strands to a larger degree, and pointing towards formation of β-barrel
structure when embedded in lipid membranes. Fluorescence data suggest that Aβ1-42 does insert
into lipid vesicle membranes and adopts β-sheet structure with twisted strands at both excitation
wavelengths. Light scattering data confirmed the presence of lipid vesicles.
Out of all 4 peptides, ATR-FTIR data for Aβ1-42 shows the strongest transition from alpha
helix to beta sheet after exposure to aqueous buffer. The β-strand tilt angle changed from 25 to
30 degrees after exposure to buffer, which is consistent with β-barrel structure of bacterial
membrane proteins (Páli and Marsh, 2000; Kleinschmidt, 2006; Zeth and Thein, 2010). Data
from Aβ1-42 provides reliable evidence for its potential pore forming capabilities. ATR-FTIR data
for Aβ1-40 showed the same β-strand tilt angle transition from 25 to 30 degrees as Aβ1-42, but the
transition from alpha helix to beta sheet was the least pronounced out of all 4 peptides. This is
perhaps due to Aβ1-40’s hydrophilic nature, and a portion of the sample was likely washed away
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by the addition of the aqueous buffer. This decreased β-sheet structure may reflect Aβ1-40’s
decreased ability to form pores in lipid membranes, but more experimentation is required to fully
conclude this. pEAβ3-40 and pEAβ3-42 ATR-FTIR data also indicate β-sheet formation and
increased β-strand tilt angle which falls in line with a β-barrel model.
Lipid order structure was also considered to determine the peptides’ effect on lipid
bilayer order. This data indicated reasonably well-organized membranes. Aβ1-42 increases the
lipid order whereas the other three peptides decrease it, revealing a unique property of Aβ1-42
compared to the other 3 peptides, which may be related to its ability to form ion-conducting
pores in membranes.

Interpretations and Implications
In order to form β-barrels, β-sheets must first exist, and in order for the β-barrel to
function as a neurotoxic ion-conducting pore, it must be embedded in the lipid membrane. In line
with the hypothesis, the results reveal that Aβ has β-sheet conformation when exposed to buffer
and that it inserts into lipid membranes. This provides further support for the amyloid hypothesis
and fits with the theory that Aβ oligomers can induce pore formation in lipid membranes.
Because only computer-generated models exist for Aβ-induced pores, these data provide
experimental evidence for the structure of Aβ in lipid membranes and strongly point towards βbarrel pore formation in lipid membranes.
These results build on existing evidence that Aβ oligomers disrupt cellular ionic
homeostasis (Dammers et al., 2015; Peters et al., 2016) by providing structural evidence for the
formation of β-barrels that function as Ca2+-permeable membrane pores. Experimental evidence
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for β-barrel structure in lipid membranes is useful in that it provides a good backing for the
hypothesis that Aβ oligomers form pores. Aβ showed substantial evidence towards pore
formation by revealing β-sheet conformation, falling in line with Kandel et al.’s 2017 study,
which reported that Aβ fragments formed the most efficient pores in lipid membranes when in βsheet conformation.

Limitations
The generalizability of the results is limited by lack of data on Aβ1-40, Aβ3-40, and Aβ3-42.
CD, fluorescence, and light scattering data was only collected for Aβ1-42 and is needed for the
other three peptides in order to best be able to compare their structures in lipid membranes.
Significant evidence points towards the existence of β-barrel structures that make up neurotoxic
membrane pores. More experimentation is needed to fully conclude Aβ’s mechanism of pore
formation.
However, the lack of CD, fluorescence, and light scattering data for on Aβ1-40, Aβ3-40, and
Aβ3-42 is a limitation only in the fact that it eliminates the chance to compare the four peptides’
structures via these methods. This lack does not impact the data that was collected for Aβ1-42, nor
does it impact that the aims of this study were achieved. Data on these three peptides for CD,
fluorescence, and light scattering are necessary for comparison, and the results that were
collected are nonetheless valid for the purposes of revealing the structure of Aβ in lipid
membranes.
These experiments were done in vitro using a vesicle model, which is much simpler than
a biological cell membrane and omits the possibility for Aβ to interact with other membrane
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proteins. However, great effort was put into mimicking biological conditions as closely as
possible with a vesicle model. Furthermore, this study does not investigate the correlation
between β-barrels and neurotoxicity because no in vivo models were used. The data merely just
proves the existence of β-barrel structures in lipid membranes which was something only
computer generated up to this point. Despite this, it cannot be said from the data collected that
these β-barrels directly cause neurotoxicity because this study did not explore that.

Future Directions
Data on the pore forming abilities of all A species studied in this work will be required
to answer questions about the mechanisms of their differential cytotoxic effects. The pore
forming capabilities of Aβ can further be explored using more spectroscopic techniques such as
NMR.
Additionally, gaining a visual image of the β-barrel in lipid membrane will provide even
more solid evidence for its existence as a neurotoxic pore. Some visual techniques that can be
explored to image Aβ structure in lipid membranes include scanning electron microscopy
(SEM), which provides picturesque images with high resolution that clearly show the lipid
membrane and the embedded β-barrel pores, and electron energy loss spectroscopy (EELS),
which can not only allow for visualization of the β-barrel in lipid membrane but also identify the
chemical nature of the sample.
Further research is needed to establish a correlation between β-barrel structure and
cytotoxicity. Cytotoxicity can be analyzed in biological models such as a cell cultures via
cytotoxicity assays, which measure the loss of cell membrane integrity upon cell death. This
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technique can be useful to pair evidence of β-barrel formation with cytotoxicity to reveal a
correlation between the β-barrel structure and cell death, liking the two together and getting
closer to proving that Aβ oligomers are capable of forming pores in lipid membranes.
This data can also provide useful information for novel drug developments and revelation
of Aβ’s full toxic pore-forming mechanism in lipid membranes. Currently, treatments for AD are
aimed at Aβ plaques and inhibition of cholinesterase and glutamate, but it would be a useful and
novel direction to target Aβ pore formation once there is enough evidence for its existence and
enough understanding of its mechanism. This way, new and possibly more effective therapeutic
directions can be developed to combat AD.
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